Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea-Reference-Cited by-同舟云学术

Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea

Published:2011-12-08 Issue:1 Volume:73 Page:140-143
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Kim Seung Young,Jung Sung Woo,Kim Jeong Han,Koo Ja Seol,Yim Hyung Joon,Park Jong Jae,Chun Hoon Jai,Lee Sang Woo,Choi Jai Hyun

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2011.04048.x/fullpdf

Reference18 articles.

1. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report;Malfertheiner;Gut,2007

2. New concepts of resistance in the treatment of Helicobacter pylori infections;Graham;Nat Clin Pract Gastroenterol Hepatol,2008

3. pH and Hp-gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism;Hunt;Am J Gastroenterol,1993

4. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy;Sugimoto;Helicobacter,2007

5. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin;Furuta;Clin Pharmacol Ther,2001

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P-CAB versus PPI in the eradication of Helicobacter pylori: a systematic review and network meta-analysis;Therapeutic Advances in Gastroenterology;2024-01

2. Dual therapy for Helicobacter pylori infection;Chinese Medical Journal;2023-01-05

3. Brief communication: global temporal trends in the efficacy of clarithromycin-based regimens for the treatment of Helicobacter pylori infection;Therapeutic Advances in Gastroenterology;2023-01

4. High‐dose amoxicillin‐proton pump inhibitor dual therapy as first‐line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial;British Journal of Clinical Pharmacology;2022-08-21

5. Potassium-Competitive Acid Blocker and Proton Pump Inhibitor–Based Regimens for First-Line Helicobacter pylori Eradication: A Network Meta-Analysis;Gastro Hep Advances;2022